# Statin Contrast Induced Nephropathy Prevention

> **NCT01185938** · PHASE4 · COMPLETED · sponsor: **Centro Cardiopatici Toscani** · enrollment: 500 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01185938
- **Lead sponsor:** Centro Cardiopatici Toscani
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2012-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01185938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01185938, "Statin Contrast Induced Nephropathy Prevention". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01185938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*